Shingrix Vaccine in Patients With Moderate to Severe Ulcerative Colitis on Tofacitinib

NCT03591770 · clinicaltrials.gov ↗
PHASE4
Phase
TERMINATED
Status
15
Enrollment
OTHER
Sponsor class

Stopped Unable to recruit adequate numbers of participants to answer the research question.

Conditions

Interventions

Sponsor

Boston Medical Center